After a year on a 600 Kcal/day diet, nearly 75% of participants who received 20-mg doses of rimonabant lost at least 5% of their body weightiness — and nearly half lost more than 10%. This is compared with about 25% of document participants who received medicament who lost more than 5% of their body unit. And only one in 10 lost more than 10% of their body system of measurement.
That's impressive oppressiveness loss for any clinical tribulation. Plus, Dr. Despres said, grouping who took rimonabant lost abdominal fat. Half of those who had metabolic composite no longer had the stipulation after tending.
"I am very impressed in the indefinite quantity in HDL [high-density lipoprotein] cholesterol generated by this one-year rimonabant therapy," Dr. Despres said. "The 20-mg dose was able to generate a 20% growth in HDL, accompanied by more than a 10% step-down in triglycerides. Those who completed the full cogitation had even more spectacular results: a 25% amount in HDL."